P62944 (AP2B1_RAT) Rattus norvegicus (Rat)
AP-2 complex subunit beta UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
25 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
AP2 controls clathrin polymerization with a membrane-activated switch |
Heteromer P18484; P62743; P63010; P84092; | 1×CL; 1×IHP; | ||||
Assess | ||||||
AP2 clathrin adaptor mu2T156-phosphorylated core in closed conformation |
Heteromer P18484; P62743; P63010; P84092; | 1×IHP; | ||||
Assess | ||||||
AP2 CLATHRIN ADAPTOR CORE |
Heteromer P18484; P62743; P63010; P84092; | 1×IHP; | ||||
Assess | ||||||
AP2 clathrin adaptor core in active complex with cargo peptides |
Heteromer P18484; P62743; P63010; P84092; | 5×SO4; | ||||
Assess | ||||||
AP2 in clathrin coats assembled on a membrane containing dileucine- and tyrosine-based cargo peptid… |
Heteromer P18484; P62743; P63010; P84092; | |||||
Assess | ||||||
AP2 on a membrane containing tyrosine-based cargo peptide |
Heteromer O43493; P18484; P62743; P63010; P84092; | |||||
Assess | ||||||
AP2 core in physiological buffer |
Heteromer P18484; P62743; P63010; P84092; | |||||
Assess | ||||||
Chimera of AP2 with FCHO2 linker domain as a fusion on Cmu2 subunit |
Heteromer P18484; P62743; P63010; P84092; | |||||
Assess | ||||||
Structure of SIVsmm Nef and SMM tetherin bound to the clathrin adaptor AP-2 complex |
Heteromer C3VHQ5; P18484; P62744; P84091; Q4JGV0; | |||||
Assess | ||||||
AP2 clathrin adaptor core in complex with cargo peptide and FCHO2 |
Heteromer P18484; P62743; P63010; P84092; Q0JRZ9; | |||||
Assess | ||||||
AP2 CLATHRIN ADAPTOR CORE with Dileucine peptide RM(phosphoS)QIKRLLSE |
Heteromer P01730; P17427; P62743; P63010; P84092; | 14×SO4; | ||||
Assess | ||||||
AP2 CLATHRIN ADAPTOR CORE with CD4 Dileucine peptide RM(phosphoS) EIKRLLSE Q to E mutant |
Heteromer P01730; P17427; P62743; P63010; P84092; | 15×SO4; | ||||
Assess | ||||||
HIV-1 Nef in complex with the CD4 cytoplasmic domain and the AP2 clathrin adaptor complex |
Heteromer P01730; P03406; P18484; P53680; P63010; Q96CW1; | |||||
Assess | ||||||
Crystal structure of AP2 FCHO2 chimera |
Heteromer P18484; P62743; P63010; P84092; Q0JRZ9; | 1×IHP; 4×GOL; | ||||
Assess | ||||||
AP2 clathrin adaptor mu2T156-phosphorylated core with two cargo peptides in open+ conformation |
Heteromer P01730; P18484; P62744; P63010; P84092; | |||||
Assess | ||||||
AP2 clathrin adaptor core with two cargo peptides in open+ conformation |
Heteromer P01730; P18484; P62743; P63010; P84092; Q3ZC13; | |||||
Assess | ||||||
B2-appendage from AP2 in complex with Eps15 peptide |
Heteromer P42566; P63010; | 3×SO4; | ||||
Assess | ||||||
beta appendage of AP2 complexed with ARH peptide |
Heteromer P63010; Q5SW96; | |||||
Assess | ||||||
Molecular basis for the association of PIPKIgamma -p90 with the clathrin adaptor AP-2 |
Heteromer O60331; | |||||
Assess | ||||||
Intersectin 1-peptide-AP2 beta ear complex |
Heteromer Q9WVE9; | |||||
Assess | ||||||
beta appendage in complex with b-arrestin peptide |
Heteromer P49407; P63010; | |||||
Assess | ||||||
Clathrin with bound beta2 appendage of AP2 |
Heteromer A0A287BFZ5; I3LGD4; P63010; | |||||
Assess | ||||||
Beta2 appendage domain of AP2 bound to terminal domains beneath the hub of the 28 triskelia mini cl… |
Heteromer I3LGD4; P63010; | |||||
Assess | ||||||
Clathrin heavy chain N-terminal domain bound to beta2 adaptin clathrin box motif |
Heteromer P49951; P63010; | |||||
Assess | ||||||
Beta2-adaptin appendage domain, from clathrin adaptor AP2 | monomer | 1×DTD; 1×MG; 2×CL; 1×GOL; | ||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
4uqi.1.B | monomer | 0.76 | 100.00 | |||
Assess |
1 SWISS-MODEL model built on isoform sequence
Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
---|---|---|---|---|---|---|
Isoform 2 | 4uqi.1.B | monomer | 0.76 | 100.00 | ||
Assess |